HIGHLIGHTS
- who: Xiya Wei from the Department of Surgery, University of Michigan, United States have published the research: The impact of Rituximab administered before transplantation in patients undergoing allogeneic hematopoietic stem cell transplantation: A real-world study, in the Journal: (JOURNAL)
- what: The aim of pre-emptive rituximab was considered to optimize the cytoreductive capability of the conditioning regimens .
- how: The authors implemented a retrospective monocentric study and utilized real-world data collected at Soochow University. For cGVHD the authors considered relapse and death as competing events. In a previous study data indicated that . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.